Mon, 25 March 2019
494: Advancing the Fight Against Breast Cancer With Novel Non-Chemotherapy Treatments - Dr. Kimberly Blackwell
Dr. Kimberly Blackwell is Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology. In addition, Kim is Co-Founder of Cereius, a company that aims to improve the lives and survival of patients with solid tumor brain metastasis by using personalized and highly targeted radiotherapy. After 25 years of treating patients and conducting breast cancer research, Kim recently left her position in academic medicine to focus her efforts on getting new drugs to patients facing cancer. Kim’s hobbies include spending time with her family, watching her son’s baseball games, practicing yoga, meditating, skiing, and horseback riding. Kim received her bachelor’s degree in bioethics from Duke University and her M.D. from Mayo Clinic Medical School. Afterwards, she completed an internship and residency in internal medicine, as well as a fellowship in hematology/oncology at Duke University Medical School. Prior to accepting her position at Lilly, Kim was a faculty member at Duke University Medical Center. Kim has received numerous awards and honors throughout her career, including the Duke University Distinguished Alumni Award, the Young Investigator Award in Breast Cancer from the National Cancer Institute Specialized Program of Research Excellence, and the Joseph Greenfield Award for Mentorship of Clinical Research. She was also recognized as one of TIME Magazine's 100 Most Influential People in the World in 2013. In our interview Kim shares more about her life and science. |
Mon, 18 March 2019
Dr. Rafael Carbunaru is Vice President of Research and Development of the Neuromodulation Division of Boston Scientific Corporation. Rafael is dedicated to creating innovative medical solutions to transform the lives of patients worldwide. He and his team are developing non-drug treatments to help patients with chronic neurological disorders such as chronic pain and Parkinson’s disease. To do this, they are creating new devices and therapies that can modify the signals the nervous system is sending that may cause the symptoms of these neurological disorders. Outside of work, Rafael enjoys spending time with his family. They like to explore outside, ride through the beautiful bike trails in Southern California, and hang out at the beach together. Rafael received his bachelor’s degree in electronics engineering from the Universidad Simon Bolivar in Venezuela. He was awarded his M.Sc. and Ph.D. degrees in biomedical engineering from Case Western Reserve University. After completing graduate school, Rafael joined the industry as an engineer for Advanced Bionics. Prior to his current role, Rafael was the Director of Research and Development for Emerging Indications at Boston Scientific. Rafael was named to the College of Fellows of the American Institute for Medical and Biological Engineering. He holds over 60 U.S. and International patents. In our interview Rafael will tell us more about his life and work. |
Mon, 11 March 2019
492: Investigating Novel Therapeutics to Improve Immune Function and Treat Age-Related Diseases - Dr. Joan Mannick
Dr. Joan Mannick is Co-Founder and Chief Medical Officer of resTORbio, a clinical-stage biopharmaceutical company that develops novel therapeutics to treat aging-related diseases. Joan and her colleagues at resTORbio are targeting the biology of aging to treat and prevent aging-related diseases so people can be healthier longer. In particular, Joan is interested in targeting the aging immune system in an effort to reduce the risk of respiratory infections in older adults. After a busy day at work, Joan likes to relax by working out at the gym, watching movies, and reading novels. Joan received her B.A. from Harvard College and her M.D. from Harvard Medical School. She completed her residency in Internal Medicine at Brigham and Women’s Hospital and a fellowship in Infectious Disease at Harvard University. Joan then worked as a Medical Director at Genzyme and a faculty member at Harvard Medical School and the University of Massachusetts Medical School. Prior to joining resTORbio, Joan was Executive Director in the New Indications Discovery Unit of the Novartis Institutes of Biomedical research. In our interview Joan shares more about her life and science. |
Mon, 4 March 2019
Dr. Stephanie Shipp is Deputy Director and Research Professor in the Social and Decision Analytics Division of the Biocomplexity Institute and Initiative at the University of Virginia. Stephanie works with social scientists and statisticians who are passionate about improving the quality of life for communities through data. They use data to inform policy-making and decision-making, working both at the scale of local communities and national projects. Stephanie develops methods and provides analyses to tell stories and answer questions using the massive amounts of data available today. When not at work, Stephanie enjoys cycling, pilates, running around with her grandchildren, and watching theatre performances with her sisters. Recently, she has also been having fun taking ballroom dancing classes with her husband. She received her B.A. Degree in Economics from Trinity College and her Ph.D. in Economics from George Washington University. Stephanie has previously held research positions at the Federal Reserve Board, the Bureau of Labor Statistics, the U.S. Census Bureau, the Department of Commerce, the National Institute of Standards and Technology, the IDA Science and Technology Policy Institute, and the Biocomplexity Institute of Virginia Tech. Stephanie has received numerous awards and honors over the course of her career, including the Pat Doyle American Statistical Association Service Award, the Jeanne E. Griffith mentoring Award, and the Bronze Medal of the Department of Commerce. She is also a Fellow of the American Association for the Advancement of Science, a Fellow of the American Statistical Association, and an elected Member of the International Statistical Institute. In our interview Stephanie shares more about her life and science. |